Enhancement of salivary esophagoprotection: Rationale for a physiological approach to gastroesophageal reflux disease

被引:56
作者
Sarosiek, J
Scheurich, CJ
Marcinkiewicz, M
McCallum, RW
机构
[1] Virginia Univ. Health Sciences Ctr., Box 1011, Charlottesville, VA 22908
关键词
D O I
10.1053/gast.1996.v110.pm8608875
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Secretion of salivary protective factors in patients with gastroesophageal reflux disease is impaired. However, the impact of physiological stimulus mastication on salivary protective factors output remains largely unknown. The aim of this study was to measure salivary volume, pH, HCO3-, peptide growth factors, prostaglandin, mucin, protein, and viscosity during mastication. Methods: In 31 asymptomatic volunteers and 36 patients with endoscopic reflux esophagitis, in basal and parafilm chewing-stimulated saliva, its volume, pH, bicarbonate, epidermal growth factor, transforming growth factor alpha, prostaglandin E(2), mucin, protein, and viscosity were investigated. Results: Masticatory stimulation in controls resulted in a significantly increased salivary volume by 205%, pH by 7.6%, bicarbonate by 335%, mucin by 137%, protein by 98%, epidermal growth factor by 123%, and prostaglandin E(2) by 132%, accompanied by an increase in transforming growth factor a by 80% with 19% decline in viscosity vs. basal values. Mastication in reflux esophagitis significantly increased salivary volume by 215%, pH by 6.8%, bicarbonate by 257%, mucin by 135%, protein by 94%, epidermal growth factor by 207%, and prostaglandin E(2) by 240%, whereas transforming growth factor a increased by 225% and viscosity by 64% when compared with corresponding basal values. Conclusions: A profound and significant increase in the secretion rate of inorganic and organic protective components in saliva during masticatory stimulation suggests its potential value as a therapeutic approach to the treatment of patients with gastroesophageal reflux disease.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 55 条
[1]   GASTRODUODENAL MUCOSAL PROTECTION [J].
ALLEN, A ;
FLEMSTROM, G ;
GARNER, A ;
KIVILAAKSO, E .
PHYSIOLOGICAL REVIEWS, 1993, 73 (04) :823-857
[2]  
CASTELL DO, 1986, J CLIN GASTROENTEROL, V8, P81
[3]  
CHEN MC, 1994, P AGA S PEPT GROWTH, P25
[4]  
DEMEESTER TR, 1991, AMBULATORY ESOPHAGEA, P81
[5]   A REPORT OF 3 MULTICLINIC TRIALS EVALUATING ARBAPROSTIL IN ARTHRITIC PATIENTS WITH ASA/NSAID GASTRIC-MUCOSAL DAMAGE [J].
EULER, AR ;
SAFDI, M ;
RAO, J ;
JASZEWSKI, R ;
WELSH, J ;
LE, V ;
RASKIN, J ;
FLEISCHMANN, R ;
RAZZAQUE, M ;
CHAMPION, C ;
GOTTLIEB, G ;
NASHEL, D ;
VANDERVEER, L ;
LEVINE, J ;
BARREIRO, M ;
CHEATUM, D ;
MENA, H ;
BUDIMANMAK, E ;
ROTH, S ;
GASKILL, H ;
LEVINE, B ;
SWINEHART, J ;
MCCLAIN, C ;
RIFF, D ;
GRAHAM, D ;
PHAN, T ;
BURNS, M ;
LOOKABAUGH, J ;
WOOD, D .
GASTROENTEROLOGY, 1990, 98 (06) :1549-1557
[6]   H-2-RECEPTOR ANTAGONISTS IN THE TREATMENT OF COMPLICATED GASTROESOPHAGEAL REFLUX DISEASE - FOR WHOM THE BELL TOLLS [J].
FENNERTY, MB ;
LIEBERMAN, D .
GASTROENTEROLOGY, 1994, 107 (05) :1545-1548
[7]  
GRAHAM DY, 1988, LANCET, V2, P1277
[8]   SALIVARY RESPONSE TO ESOPHAGEAL ACID IN NORMAL SUBJECTS AND PATIENTS WITH REFLUX ESOPHAGITIS [J].
HELM, JF ;
DODDS, WJ ;
HOGAN, WJ .
GASTROENTEROLOGY, 1987, 93 (06) :1393-1397
[9]  
HELM JF, 1982, GASTROENTEROLOGY, V83, P69
[10]   EFFECT OF ESOPHAGEAL EMPTYING AND SALIVA ON CLEARANCE OF ACID FROM THE ESOPHAGUS [J].
HELM, JF ;
DODDS, WJ ;
PELC, LR ;
PALMER, DW ;
HOGAN, WJ ;
TEETER, BC .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (05) :284-288